[NCEH] Enhancing Data-driven
Disease Detection in Newborns (ED3N)
Extension without change of a currently approved collection
No
Regular
03/09/2026
Requested
Previously Approved
36 Months From Approved
04/30/2026
19,363
19,363
1,042
1,042
0
0
CDC's Newborn Screening and Molecular
Biology Branch (NSMBB) is developing a National Newborn Screening
Data Platform (known as ED3N) that will address analytic and
post-analytic challenges and promote sharing of molecular,
biochemical, and clinical information amongst state-based newborn
screening (NBS) partners. The information shared will help NSMBB
and newborn screening partners be better equipped to assess disease
risk and will help harmonize approaches for disease detection in
newborns. Given the rarity of newborn screening diseases, it is
imperative that data be collected and analyzed at a national level
in order to glean useful insights and trend analyses. The NSMBB is
best-suited to oversee this work given its role in providing
technical assistance to NBS programs nationally. This is an
Extension of the previous submission.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
03/09/2026
Something went wrong when
downloading this file. If you have any questions, please send an
email to risc@gsa.gov.